Quick Answer
Cue Biopharma, Inc. reported Total Revenue of $27.47 million for fiscal year 2025.
Cue Biopharma, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $27.47M | +195.7% |
| 2024 | $9.29M | +69.2% |
| 2023 | $5.49M | +341.0% |
| 2022 | $1.25M | -91.7% |
| 2021 | $14.94M | +373.7% |
| 2020 | $3.15M | -8.8% |
| 2019 | $3.46M | +202.7% |
| 2018 | $1.14M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.15M | -35.6% | -27.3% |
| June 30, 2025 | $2.95M | +11.1% | +601.7% |
| March 31, 2025 | $421.0K | -75.5% | -87.4% |
| September 30, 2024 | $3.34M | +58.9% | +25.5% |
| June 30, 2024 | $2.66M | +92.3% | +54.8% |
| March 31, 2024 | $1.72M | +818.2% | -18.2% |
| September 30, 2023 | $2.10M | +2988.2% | +52.0% |
| June 30, 2023 | $1.38M | +5215.4% | +639.0% |
- Cue Biopharma, Inc. showed an increase of +195.7% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, Cue Biopharma, Inc.’s total revenue has grown by 2303.8% (from $1.14 million to $27.47 million).
- The most recent figure is from Cue Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: